HELP     Sign In
Search

Relevance to Autism

This gene, formerly known as ERBB2IP, was originally identified as an ASD candidate gene based on its enrichment in an autism-associated protein interaction module. Sequencing of post-mortem brain tissue from 25 ASD cases resulted in the identification of significant non-synonymous variants in this gene with an expected false-positive rate at 0.1, confirming the involvement of this module with autism; this finding was further validated by exome sequencing of an independent cohort of 505 ASD cases and 491 controls (Li et al., 2014). This gene was identified by TADA (transmission and de novo association) analysis of a combined dataset from the Simons Simplex Collection (SSC) and the Autism Sequencing Consortium (ASC) as a gene strongly enriched for variants likely to affect ASD risk with a false discovery rate (FDR) of <0.1 (Sanders et al., 2015); among the variants identified in this gene was one de novo loss-of-function (LoF) variant.

Molecular Function

This gene is a member of the leucine-rich repeat and PDZ domain (LAP) family that binds to the unphosphorylated form of the ERBB2 protein and regulates ERBB2 function and localization. It has also been shown to affect the Ras signaling pathway by disrupting Ras-Raf interaction.

External Links

        

References

Type
Title
Type of Disorder
Associated Disorders
Author, Year
Primary
Integrated systems analysis reveals a molecular network underlying autism spectrum disorders.
ASD
Support
Massively parallel reporter assays discover de novo exonic splicing mutants in paralogs of Autism genes
ASD
Support
Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks.
ASD
Support
Excess of rare, inherited truncating mutations in autism.
ASD
Support
Synaptic, transcriptional and chromatin genes disrupted in autism.
ASD
Support
Integrating de novo and inherited variants in 42
ASD
Recent Recommendation
Insights into Autism Spectrum Disorder Genomic Architecture and Biology from 71 Risk Loci.
ASD
Recent Recommendation
Low load for disruptive mutations in autism genes and their biased transmission.
ASD

Rare

Variant ID
Variant Type
Allele Change
Residue Change
Inheritance Pattern
Inheritance Association
Family Type
Author, Year
 GEN678R001 
 missense_variant 
 c.821C>T 
 p.Ser274Leu 
 Unknown 
  
 Unknown 
 GEN678R002 
 splice_site_variant 
 c.1307-2A>T 
  
 De novo 
  
 Simplex 
 GEN678R003 
 missense_variant 
 c.1292C>T 
 p.Pro431Leu 
 De novo 
  
 Simplex 
 GEN678R004 
 frameshift_variant 
 c.1043_1044del 
 p.Thr348SerfsTer8 
 Familial 
 Paternal 
 Multiplex 
 GEN678R005 
 stop_gained 
 c.3958C>T 
 p.Gln1320Ter 
 De novo 
  
  
 GEN678R006 
 stop_gained 
 c.1461C>A 
 p.Tyr487Ter 
 Familial 
 Paternal 
 Multiplex 

Common

No Common Variants Available
Chromosome
CNV Locus
CNV Type
# of studies
Animal Model
5
Deletion
 1
 
5
Duplication
 1
 
5
Deletion-Duplication
 10
 
5
Deletion
 1
 

Model Summary

Both Erbin null and the PDZ-domain truncation mutants display decreased myelination in PNS but not in CNS. The nonmyelinating axon ensheathment of sciatic nerves is also affected in these mutants. These abnormalities can be reflected by the decreased tail nerve motor conduction and pain sensitivity.

References

Type
Title
Author, Year
Primary
Erbin regulates NRG1 signaling and myelination.

M_ERBIN_1_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Exons 1 and 2 of erbin gene were replaced in erbin-targeting vector by a neomycin-resistant marker flanked with LoxP sites.
Allele Type: Targeted (Knock Out)
Strain of Origin: Not specified
Genetic Background: Not specified
ES Cell Line: 129 Ola
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_ERBIN_2_KO_HM

Model Type: Genetic
Model Genotype: Homozygous
Mutation: Erbin gene disrupted by gene trapping using the pGT2Lxf vector resulted in a C-terminal PDZ motif truncated product (truncated form missing exon 21 to 24).
Allele Type: Gene trapped
Strain of Origin: Not specified
Genetic Background: C57/Bl6; Bga258
ES Cell Line: Bga258
Mutant ES Cell Line: Not specified
Model Source: Not specified

M_ERBIN_1_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Perineuronal net morphology1
Decreased
Description: The number of unmyelinated axons was significantly increased in remak bundles where axons were small and were compacted to each other and not completely segregated in the mutant sciatic nerves
Exp Paradigm: Electron microscopy
 Electron microscopy
 4 weeks
Myelination: pns1
Decreased
Description: The myelin of sciatic nerve axons was significantly thinner with normal myelination initiation, radial sorting, and compaction in mutant mice compared to that of littermate controls
Exp Paradigm: Axon diameters/fiber diameters (g-ratio) of myelinated axons
 G-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 P8, 4 weeks
Pain or nociception: mechanical1
Decreased
Description: Increased sensory threshold (the smallest strength of von frey hair) in the mutant mice compared to the littermate controls
Exp Paradigm: Hindpaws were stimulated by von frey hair
 Von frey filament test
 8 weeks
Tail nerve motor conduction1
Decreased
Description: Decreased conduction velocity in the tail nerve of mutant mice
Exp Paradigm: 2 ring electrodes at different proximal tail locations were used as stimuli. an electrode placed at the distal region was used to record the conduction, with tail tips grounded by a clip electrod
 Tail action potential recording
 8 weeks
Signaling: pi3k/ akt1
Decreased
Description: Decreased level of phospho-akt in mutant sciatic nerves compared to littermate controls
Exp Paradigm: Western blot: phospho-akt
 Western blot
 P4, p10, p25, and p40
Protein expression level evidence1
Decreased
Description: Decreased protein levels of p0 (mpz), erbb2, or erbb3 in mutant sciatic nerves compared to littermate controls
Exp Paradigm: Western blot: p0 (mpz), erbb2, erbb3
 Western blot
 P5, p15, p25, or p40
Gene expression1
 No change
 Polymerase chain reaction (pcr)
 P5, p15, and p42
Marker expression1
 No change
 Immunostaining
 P1, p5, p15, p25, or p40
Marker expression1
 No change
 Western blot
 P1, p5, p15, p25, or p40
Protein expression level evidence1
 No change
 Western blot
 P1, p5, p15, p25, and p40
Protein expression level evidence1
 No change
 Immunostaining
 P7, p15, p25, and p40
Protein expression level evidence1
 No change
 Western blot
 P7, p15, p25, and p40
Myelination1
 No change
 G-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 4 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Social behavior

M_ERBIN_2_KO_HM

Category
Entity
Quantity
Experimental Paradigm
Age at Testing
Myelination: pns1
Decreased
Description: The myelin of sciatic nerve axons was significantly thinner with normal myelination initiation, radial sorting, and compaction in mutant mice compared to that of littermate controls
Exp Paradigm: Axon diameters/fiber diameters (g-ratio) of myelinated axons
 G-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 P8, 4 weeks
Perineuronal net morphology1
Decreased
Description: The number of unmyelinated axons was significantly increased in remak bundles where axons were small and were compacted to each other and not completely segregated in the mutant sciatic nerves
Exp Paradigm: Electron microscopy
 Electron microscopy
 4 weeks
Tail nerve motor conduction1
Decreased
Description: Decreased conduction velocity in the tail nerve of mutant mice
Exp Paradigm: 2 ring electrodes at different proximal tail locations were used as stimuli. an electrode placed at the distal region was used to record the conduction, with tail tips grounded by a clip electrod
 Tail action potential recording
 8 weeks
Pain or nociception: mechanical1
Decreased
Description: Increased sensory threshold (the smallest strength of von frey hair) in the mutant mice compared to the littermate controls
Exp Paradigm: Hindpaws were stimulated by von frey hair
 Von frey filament test
 8 weeks
Protein expression level evidence1
Decreased
Description: Decreased protein levels of p0 (mpz), erbb2, or erbb3 in mutant sciatic nerves relative to littermate controls
Exp Paradigm: Western blot: p0 (mpz), erbb2, erbb3
 Western blot
 P5, p15, p25, or p40
Gene expression1
 No change
 Polymerase chain reaction (pcr)
 P5, p15, and p42
Marker expression1
 No change
 Immunostaining
 P1, p5, p15, p25, or p40
Marker expression1
 No change
 Western blot
 P1, p5, p15, p25, or p40
Protein expression level evidence1
 No change
 Immunostaining
 P7, p15, p25, and p40
Protein expression level evidence1
 No change
 Western blot
 P7, p15, p25, and p40
Myelination1
 No change
 G-ratio measurement (axon diameters/fiber diameters of myelinated axons)
 4 weeks
 Not Reported: Circadian sleep/wake cycle, Communications, Developmental profile, Emotion, Immune response, Learning & memory, Maternal behavior, Motor phenotype, Neurophysiology, Physiological parameters, Repetitive behavior, Seizure, Social behavior

No PIN Data Available
HELP
Copyright © 2017 MindSpec, Inc.